H L Hillege - JoVE Visualize

Showing results (41-50 of 57) with videos related to

Pageof 6

Sort By:

Diabetologia|April 25, 2012

Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyA Abbasi, E Corpeleijn, E Meijer, et al.

Thrombosis and Haemostasis|January 1, 1996

Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective studyJ van der Meer, H L Hillege, C A Ascoop, et al.

Diabetologia|June 14, 2019

Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyA Abbasi, E Corpeleijn, E Meijer, et al.

Journal of Internal Medicine|October 27, 2011

The fibrosis marker galectin-3 and outcome in the general populationR A de Boer, D J van Veldhuisen, R T Gansevoort, et al.

Journal of the American College of Cardiology|November 1, 1994

Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon StudyJ van der Meer, A Brutel de la Rivière, W H van Gilst, et al.

European Heart Journal|November 10, 2000

Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) studyG F Diercks, A J van Boven, H L Hillege, et al.

European Heart Journal|June 1, 1994

The 'Ermenonville' classification of observations at coronary angioscopy--evaluation of intra- and inter-observer agreement. European Working Group on Coronary AngioscopyP den Heijer, D P Foley, H L Hillege, et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2007

Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational studyC A Geluk, R A Tio, J G P Tijssen, et al.

Circulation|November 1, 1994

A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The NetherlandsJ van der Meer, H L Hillege, W H van Gilst, et al.

International Journal of Clinical Pharmacology and Therapeutics|November 23, 2005

Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failureT D J Smilde, G C M Linssen, D Gallemann, et al.

Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:

Pageof 6

Diabetologia|April 25, 2012

Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyA Abbasi, E Corpeleijn, E Meijer, et al.

Thrombosis and Haemostasis|January 1, 1996

Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective studyJ van der Meer, H L Hillege, C A Ascoop, et al.

Diabetologia|June 14, 2019

Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyA Abbasi, E Corpeleijn, E Meijer, et al.

Journal of Internal Medicine|October 27, 2011

The fibrosis marker galectin-3 and outcome in the general populationR A de Boer, D J van Veldhuisen, R T Gansevoort, et al.

Journal of the American College of Cardiology|November 1, 1994

Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon StudyJ van der Meer, A Brutel de la Rivière, W H van Gilst, et al.

European Heart Journal|November 10, 2000

Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) studyG F Diercks, A J van Boven, H L Hillege, et al.

European Heart Journal|June 1, 1994

The 'Ermenonville' classification of observations at coronary angioscopy--evaluation of intra- and inter-observer agreement. European Working Group on Coronary AngioscopyP den Heijer, D P Foley, H L Hillege, et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2007

Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational studyC A Geluk, R A Tio, J G P Tijssen, et al.

Circulation|November 1, 1994

A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The NetherlandsJ van der Meer, H L Hillege, W H van Gilst, et al.

International Journal of Clinical Pharmacology and Therapeutics|November 23, 2005

Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failureT D J Smilde, G C M Linssen, D Gallemann, et al.

Pageof 6